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Bacterial pathogenesisThe Type III Secretion System (T3SS) is a multi-mega Dalton apparatus assembled frommore than twenty com-
ponents and is found in many species of animal and plant bacterial pathogens. The T3SS creates a contiguous
channel through the bacterial and host membranes, allowing injection of specialized bacterial effector proteins
directly to the host cell. In this review, we discuss our current understanding of T3SS assembly and structure,
as well as highlight structurally characterized Salmonella effectors. This article is part of a Special Issue entitled:
Protein trafﬁcking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
More than two decades ago, the observation that Yersinia “Yop”
virulence, or effector proteins were translocated into host cells in a
Sec-independent manner without cleavage of an N-terminal sequence
[1] led to the proposed existence of an alternative secretion system,
named the Type III Secretion System (T3SS) [2]. The presence of a spe-
cialized secretion system unique only to pathogenic strains of bacteria
was also supported by the identiﬁcation of the inv genetic locus
contained within the Salmonella Pathogenicity Island I (SPI-1), a gene
cluster in Salmonella required for invasion [3,4], and the observation of
homology between InvG, a protein encoded in the inv operon, and the
outer membrane secretin of the Type II secretion system (T2SS) PulD
(as well as additional inv proteins and ﬂagella proteins [5,6]). Addition-
ally, a second gene cluster encoding a distinct T3SS was identiﬁed in
Salmonella [7] (named SPI-2, for Salmonella Pathogenicity Island 2). Clus-
ters of genes that encode a T3SS have since been discovered in a number
of animal and plant bacterial pathogens, as well as symbiotic bacteria,
and have been classiﬁed into families based on sequence conservation.
The best-characterized mammalian pathogens can be classiﬁed into
three families: Inv-Mxi-Spa family contains Salmonella spp. SPI-1, and
Shigella ﬂexneri; the Ysc family contains Yersinia spp. and Pseudomonas
aeruginosa; and the Ssa-Esc family contains enteropathogenic Escherichia
coli (EPEC), and Salmonella spp. SPI-2. Unfortunately, nomenclature is not
consistent between species (Table 1); the emphasis in this reviewwill be
to use the Salmonella SPI-1 naming.
The ﬁrst electron microscopy (EM) images of the Salmonella [8] and
Shigella [9,10] T3SS revealed a remarkable syringe-like appearance: ain trafﬁcking and secretion in
ss Dalbey.
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cellular needle that protruded to the extracellular space. Since these
ﬁrst images, the ﬁeld has made appreciable progress in the structural
and mechanistic characterization of the N20 components which com-
prise the conserved T3SS apparatus in a variety of bacterial pathogens,
as well as that of the more diverse sets of species-speciﬁc virulence
effector proteins that are delivered by the T3SS with the aid of cognate
bacterial chaperones.
In this reviewwe will begin with a brief introduction of biochemical
and genetic evidence for chronological T3SS assembly, followed by a
structural overview of the T3SS speciﬁc chaperones and themajor com-
ponents of the T3SS (the innermembrane export apparatus, the contin-
uous hollowed shell that spans from the inner to the outer membranes
known as the basal body, and the extracellular needle and translocon
(needle tip) complex that provides a direct hollowed conduit into in-
fected host cells). Finally, a brief survey of structurally characterized
Salmonella effector proteins will also be presented. The emphasis of
this review will be the presentation of recent T3SS structure/function
analysis, with a focus on the prototypical Salmonella SPI-1 proteins,
although structurally characterized orthologs from other species will
be discussed when relevant.2. Assembly of the T3SS
The T3SS is composed of more than 20 proteins (Fig. 1A), many of
which form oligomers and are membrane embedded. During infection,
the bacteria receive an external cue from the host environment and
begin to assemble the constituents of the secretion system, a process
that must be coordinated in space and time. Assembly can be catego-
rized into discrete stages: 1) assembly of the basal body rings and ex-
port apparatus, 2) assembly of the inner rod and needle, 3) assembly
of the tip and translocon, and 4) secretion of effectors. The precise
Table 1
Nomenclature of T3SS components from selected animal-pathogenic bacteria.
Structure Component Species
Salmonella typhimuruium (SPI-1) Shigella ﬂexneri EPEC Yersinia spp. Pseudomonas aeruginosa
Export apparatus ATPase InvC Spa47 EscN YscN PscN
Central stalk InvI Spa13 Orf15 YscO PscO
Peripheral stalk OrgB MxiL EscL YscL PscL
C-ring homolog SpaO Spa33 SepQ YscQ PscQ (HcrQ)
Gate InvA MxiA EscV YscV (LcrD) PcrD
Gate-keeper InvE MxiC SepL/SepD YopN/TyeA PopN
Autoprotease SpaS Spa40 EscU YscU PscU
IM component SpaP Spa24 EscR YscR PscR
IM component SpaR Spa29 EscT YscT PscT
IM component SpaQ Spa9 EscS YscS PscS
Basal body IM ring PrgH MxiG EscD YscD PscD
IM ring PrgK YscJ EscJ YscJ PscJ
OM ring InvG MxiD EscC YscC PscC
Pilotin InvH MxiM N/A YscW ExsB
Inner rod PrgJ MxiI EscI YscI PscI
Needle Filament PrgI MxiH EscF YscF PscF
Tip Tip SipD IpaD EspA LcrV PcrV
Translocon Minor subunit SipB IpaB EspD YopB PopB
Major subunit SipC IpaC EspB YopD PopD
Accessory proteins Lytic transglycosylase IagB IpgF EtgA - -
Needle length regulator InvJ Spa32 EscP YscP PscP
Abbreviations: (SPI-1),Salmonella Pathogenicity Island 1; IM, inner membrane; OM, outer membrane.
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several models have been proposed, and studies indicate that some
facets of the assembly may vary between species.
Assembly of the basal body and export apparatus has been described
by an “inside-out” process in Salmonella [11] and an “outside-in” pro-
cess in Yersinia [12,13]. In the Salmonella inside-out model, the export
apparatus components SpaP and SpaR initiate assembly at the inner
membrane and recruit the remaining export apparatus components
SpaQ and SpaS. The inner membrane ring components of the basal
body, PrgH and PrgK, then assemble at the site of the export apparatus.
The secretin outer membrane protein InvG is transported via the Sec
pathway and, with the aid of a lipidated chaperone known as a T3SS
pilotin [14–16], forms an oligomer in the outer membrane. This model
is supported by the observations that the export apparatus can assem-
ble in the absence of the needle complex [11], that the innermembrane
ring can assemble in the absence of InvG [17] and that InvG homolog in
EPEC, EscC, requires the inner membrane ring for correct localization
[18]. It has been shown that the basal body can assemble in the absence
of the export apparatus; however, this structure lacks the inner socket
and cup substructures and is a dead end for assembly [11]. In the
Yersinia outside-in model, the secretin inserts ﬁrst into the outer mem-
brane, and then the inner membrane ring component YscD (PrgH
homolog) and the export apparatus assembles in parallel. Assembly is
completed by recruitment of the second inner membrane ring protein,
YscJ (PrgK) and the cytoplasmic ATPase and C-ring. The two models
may reﬂect divergent assembly pathways between species.
The next stage of assembly, formation of the inner rod (the pre-
sumed inner channel of the basal body) and the contiguous hollowed
needle that protrudes from the extracellular face of the basal body, re-
quires ATPase activity [19], indicating that it proceeds after assembly
of the functional basal body and export apparatus. Needle length is con-
stant within species, and is likely optimized for contact with the host
cell [20]; therefore, regulation of needle length is an important aspect
of T3SS assembly. Needle length regulation has been proposed to be
controlled by Type 3 substrate speciﬁcity switch proteins, which may
function as a “molecular ruler” [21], or conversely, needle length may
be regulated by the inner rod [22]. These switch proteins share little se-
quence identity, but have a structurally conserved C-terminal domain
[23]. In Yersinia and EPEC, the switch proteins YscP and EscP interact
with the T3SS autoprotease proteins YscU and EscU, respectively, in
the bacterial cytosol [24,25], and may play a role in regulating thesubstrate switching event associated with auto-cleavage of the
autoprotease (see below), although the mechanistic details are not
well understood. Themolecular ruler model was proposed from the ob-
servation that deletions in YscP resulted in shorter needles, whereas in-
sertions resulted in longer needles [21]. In this model, the C-terminal
globular domain of YscP is thought to be associated with the base of
the T3SS, and the N-terminal region extends through the inner channel
of the nascent needle until it is stretched to its limit; this in turn induces
a conformational change at the base of the T3SS, terminating secretion
of the needle. Interestingly, expression of two constructs of YscP, one
longer relative to the other, in Yersinia resulted in a population with
two distinct needle lengths rather than an intermediate needle length,
suggesting that only one molecule of YscP is required per secretion ap-
paratus [26]. Additionally, the helical content of YscP may play a role in
needle length regulation, as disruption of N-terminal helices by de-
signed mutation also altered needle length [27]. YscP also regulates se-
cretion of the inner rod, as the inner rod is hyper secreted in the absence
of YscP, which in turn affects the length of the needle [28]. An alterna-
tive mechanism involving the inner rod-mediated control of needle
length was proposed after the observation that deletion of Salmonella
switch protein InvJ resulted in needle complexes without inner rod
but long labile needles [22]. The needle and the inner rod are exported
simultaneously, and after completion of the inner rod, a proposed con-
formational change occurs at the base of the secretion system, triggering
a substrate switching event. In the absence of the rod, which requires
InvJ for proper assembly, the needle is continuously exported, resulting
in long needles.
Secretion of effector proteins is controlled by an additional protein,
InvE (Salmonella), YopN/TyeA (Yersinia), MxiC (Shigella) and SepD/
SepL (EPEC), which is localized to the bacterial membrane [29] likely
via interaction with components of the T3SS [30,31]. Structures of
YopN/TyeA (as well as YopN with its chaperones SycN/YscB) [32] and
MxiC [33] have been solved, revealing three conserved 4-helix
X-bundle fold domains with the third domain of MxiC homologous to
TyeA [34]. This group of proteins has been proposed to act as a “gate-
keeper” based on the observation that deletion of the protein results
in decreased or abolished secretion of translocon proteins, and in
some instances increased secretion of effectors [29,30,35–38]. MxiC,
InvE and YopN/TyeA were all shown to interact with the inner rod,
although the precise purpose of this interaction has yet to be discerned
[31].
Fig. 1. A) Structural overview of T3SS injectisome (adapted from [206]). PDB accession codes of solved structural components are listed in Table 2. B) ssNMR analysis of the Salmonella
needle ﬁlament. Left— view through the needle channel looking from the top down. Each PrgI subunit has a unique color and the N-terminal domain (demarcated N) faces the extracel-
lular space. Right— lateral interface between needle subunit i (olive) and i+ 5 (purple), and i+ 6 (orange) and axial interface between i and i+11 demonstrate intersubunit interactions
that occur during formation of the needleﬁlament. C) Left— InvG (blue), PrgH (orange) and PrgK (purple) ringmodels. Center— cut away of Salmonellaneedle complex EMstructurewith
one subunit each of InvG, PrgK and PrgH to show relative localization of subunits within the basal body. Right— subunit–subunit interactions occur via “ring-building”motifs. The inset
shows interactions between two PrgH periplasmic domains. Each ring buildingmotif consists of 3 beta sheets and two alpha helices. D. Left— top view of the nonamericMxiA export gate
with each subunit colored uniquely. The pore diameter is ~50 Å. Right— side view ofMxiAnonameric ring. The ring has a depth of ~55 Å and a funnel-like shapewith an external diameter
of 110 Å at the cytoplasmic facing end and an external diameter of 170 Å at the membrane facing end.
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Within the bacterial cytoplasm, specialized chaperones bind T3SS
substrates and deliver them to the ATPase anchored at the cytoplasmic
face of the T3SS assembly. All evidence indicates these chaperones are
released back to the cytoplasmwith only the cognate effector substrate
shuttled into the export apparatus [39] for secretion. T3SS chaperones
have been shown to prevent premature degradation and oligomeriza-
tion of substrates, aswell as undesirable interactionswith bacterial pro-
teins and the bacterial membrane [40], and may also help establish a
secretion hierarchy of substrates [41]. Chaperones can be divided into
several classes: class IA (or uni-effector) chaperones speciﬁcally bind
one effector, class IB (ormulticargo) chaperones associatewithmultiple
effectors, class II chaperones bind translocon proteins, and class III
chaperones associate with needle subunits. A number of chaperones
have been structurally characterized, both as homo- or heterodimers,
as well as in complex with their cognate substrate (See Table 3).
Although there is diversity amongst the various species, chaperones
are typically small, acidic proteins, and may function as homodimers
or heterodimers.3.1. Class IA and IB chaperones
Class IA and IB chaperones typically bind the N-terminal region of ef-
fectors, a region referred to as the chaperone binding domain, covering
the ﬁrst 50–100 amino acids of the effector. Generally, the N-terminal
region of the effectors adopts a non-globular conformation and wrap
around the surface of the chaperone. An intriguing similarity observed
between co-crystal structures of both class IA and IB effector/chaperone
pairs SptP/SicP [42], YopE/SycE [43], YopN/SycN–YscB [32], YscM2/SycH
[44], SipA/InvB [45] and YopH/SycH [46] is the presence of a so-called
“β-motif” within the chaperone binding domain of the effector, which
forms an intermolecular β-sheet interaction with the chaperone, thus
behaving as a conserved targeting motif [45]. While the N-terminal
regions of effectors interact with the chaperone in a non-globular con-
formation, some effectors retain catalytic activity of their C-terminal
domain when in complex with the chaperone, indicating that the
C-terminal domain retains a globular fold [47]. The process of effector
translocation through the needle has been described as “threading the
needle” [48], implying that theN-terminal domain of the effector, main-
tained in an unfolded conformation by interaction with the chaperone,
Table 2
Structures of T3SS components.
Component Protein name Species Method PDB/EMDB codes
ATPase EscN EPEC x-ray [85] 2OBM
C-Ring homolog HcrQ Pseudomonas syringae x-ray [207] 1OY9
Gate InvA Salmonella x-ray [80,81] 2X49, 3LW9
MxiA Shigella x-ray [79] 4A5P
Gate-keeper MxiC Shigella x-ray [33] 2VJ4
YopN/TyeA Yersinia x-ray [32] 1XL3
Autoprotease SpaS Salmonella x-ray [77] 3C01
Spa40 Shigella x-ray [72] 2VT1
EscU EPEC x-ray [70] 3BZL
YscU Yersinia x-ray [73,74] 2JL1
Needle Complex PrgH, PrgK, InvG Salmonella EM [67] 1875
MxiG, MxiJ, MxiD Shigella EM [93] 1617
Injectisome with trapped substrate Salmonella EM [164] 2481, 2482
In situ injectisome Shigella Cryo-ET [68] –
In situ injectisome Yersinia Cryo-ET [68] –
In situ injectisome Salmonella Cryo-ET [69] –
Basal Body IM Ring EscJ EPEC x-ray [95] 1YJ7
PrgH/PrgK Salmonella EM [67] 1874
PrgH (cytoplasmic) Salmonella x-ray [94] 4G2S
PrgH (periplasmic) Salmonella x-ray [94,96] 3GR0, 4G1I
MxiG Shigella NMR, x-ray [97,98] 2XXS, 4A4Y
Pilotin MxiM Shigella x-ray [102] 1Y9L
Pilotin-Secretin MxiM-MxiD Shigella NMR [104] 2JW1
Secretin InvG Salmonella EM [67] 1871
YscC Yersinia EM [105] 5720–5722
InvG (periplasmic) Salmonella x-ray [94] 4G08
Needle PrgI Salmonella x-ray [118] 2X9C
NMR [117,118] 2KV7, 2JOW
PrgI Salmonella ssNMR [122] 2LPZ
MxiH Shigella x-ray [115] 2CA5
Negative stain EM [115] 1416
Cryo-EM [127] 5352
ssNMR, PrgI homology model [205] –
YscF/YscG/YscE Yersinia x-ray [64] 2P58
PscF/PscG/PscE Pseudomonas x-ray [63] 2UWJ
BsaL Burkholderia NMR [116] 3G0U
Tip SipD Salmonella x-ray [142] 3NZZ
SipD/PrgI Salmonella x-ray [143] 3ZQB
IpaD Shigella x-ray [145] 3R9V
LcrV Yersinia x-ray [138] 1R6F
EspA/CesA EPEC x-ray [66] 1XOU
BipD Burkholderia x-ray [144] 21XR
Translocon PopB/PcrH Pseudomonas x-ray [56] 2XCB
IpaB/IpgC Shigella x-ray [60] 3ZG1
YopD/SycD Yersinia x-ray [58] 4AM9
IpaB Shigella x-ray [162] 3U0C
SipB Salmonella x-ray [162] 3TUL
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globular C-terminal domain, concomitant with the ATP hydrolysis and
consequent release of the chaperone, allows for passage of the effector
in a partially unfolded state.
Class IA chaperones bind a speciﬁc effector usually encoded in a gene
adjacent to the chaperone gene, and translation of the chaperone has
been shown to be coupled to expression of the effector [49]. Structurally
characterized examples of class IA chaperones in Salmonella include
SigE [47], which binds effector SopB, as well as SicP [42], which binds
effector SptP. Both SigE and SicP have a mixed α/β-fold and function
as homodimers. The N-terminal chaperone binding domain of SptP
interacts with SicP dimer in an extended conformation through hydro-
phobic patches on each chaperonemonomer surface [42], an interaction
that exempliﬁes complex formation between effectors and class I
chaperones.
Class IB chaperones are often encoded near genes for structural
components of the T3SS and interact with multiple substrates [50].
Structures from various species indicate that, like their class IA counter-
parts, IB chaperones contact their effectors in an extended non-globular
fashion via dispersed clusters of largely nonpolar interactions (for ex-
ample, as seen in Yersinia YopE/SycE [43], and YscM2/SycH [44] ). The
Salmonella class IB chaperone InvB is encoded between the T3SS exportapparatus component InvA and the ATPase InvC within the invABC
locus and binds effectors SipA [51], SopE/E2 [52,53], and SopA [54]. A
feature unique to the latter two of these effectors (as well as their ho-
mologs) which interact with the Shigella chaperone Spa15 (31%
sequence identity to InvB) is the presence of a conserved sequence
(LMIF)xxx(IV)5xx(IV)8x(N)10 which resides within the above men-
tioned β-motif [55] structural region of these proteins. Interestingly,
Spa15 and InvB can function interchangeably to bind and facilitate se-
cretion of effectors containing this conserved sequence [55], suggesting
that it acts as a conserved class IB chaperone targeting motif.
3.2. Class II chaperones
Class II chaperones contain tetratricopeptide (TPR) repeats and are
required for secretion of the two T3SS translocon proteins that form
the pore-forming complex in the infected host cell membrane (these
proteins are often termed major and minor based on their proposed
prevalence in the complex). Structures of Pseudomonas PcrH with a
PopD [56] peptide, Yersinia SycD [57] with a YopD [58] peptide, and
Shigella IpgC [59] with a IpaB [60,61] peptide reveal a conserved chaper-
one fold of TPR repeats with a “cupped palm” surface which forms a
binding groove for theminor ormajor translocon peptide. Stoichiometry
Table 3
Structures of chaperone and chaperone/substrate complexes.
Species Chaperone Co-crystallized
substrate/effector
PDB code
Salmonella SicP SptP CBD 1JYO [42]
SigE – 1K3S [47]
InvB SipA CBD 2FM8 [45]
Shigella Spa15 – 1rY9 [208]
IpgC – 3GYZ, SKS2 [59,60]
IpgC IpaB fragment, CBD 3GZ1, 3GZ2 [60,61]
EPEC CesT – 1K3E [47]
CesAB – 2M1N [209]
CesA (CesAB) EspA 1XOU [66]
Yersinia SycE – 1JYA, 1K62, and
1N5B [210–212]
SycE YopE CBD 1L2W [43]
SycT – 2BSH, 2BSI, and
2BHO [213,214]
SycD – 2VGX [57]
SycH YscM2 CBD 1TTW [44]
SycH YopH CBD 4GF3 [46]
SycN-YscB YopN 1XKP [32]
YscE-YscG YscF 2P58 [64]
SycD YopD fragment 4AM9 [58]
Pseudomonas
aeruginosa
SpcU ExoU 4AKX, 3TU3 [215,216]
PscE-PscG PscF 2UWT [63]
PcrH – 2XCC [56]
PcrH PopD fragment 2XCB [56]
Abbreviations: CBD, chaperone binding domain.
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observed to date. Structures of the full-length translocon/effector com-
plex could help discern the ternary structure of the complex; however,
the full-length translocon may interact with the chaperone in a molten
globule conformation [62], impeding crystallization.
3.3. Class III chaperones
Class III chaperones form heterodimers and associate with needle
subunits in a 1:1:1 ternary complex to prevent polymerization of the
needle in the bacterial cytosol. Structures of Pseudomonas PscG/PscE/
PscF [63], Yersinia YscG/YscE/YscF [64] and Aeromonas AscG/AscE [65]
complexes have been solved. The PscG/YscG/AscG chaperone has a
TPR fold that binds the C-terminal helix of the needle subunit (PscF/
YscF) via hydrophobic residues of its concave surface. The second chap-
erone, PscE/YscE/AscE, has twomainα-helices and associates primarily
with PscG/YscG/AscG, perhaps stabilizing the TPR chaperone. It is inter-
esting to note that the heterodimeric chaperoning system of the needle
subunit diverges from the chaperone of the EPEC ﬁlament protein EspA
(essentially an elongated extension of the needle component in that
species), in which a single hairpin structured chaperone CesA bound
to EspA in a 1:1 ratio is sufﬁcient to impede polymerization of EspA [66].
4. Architecture of the T3SS apparatus
4.1. The export apparatus and ATPase
The export apparatus is composed of ﬁvemembrane proteins (SpaP,
SpaQ, SpaR, SpaS and InvA in Salmonella), as well as a soluble ATPase
complex. The membrane components of the export apparatus localize
to the inner membrane, initiating with assembly of SpaP, SpaQ and
SpaR [11] (YscR, YscS, and YscT in Yersinia) [12] and associate with the
base of the needle complex, where they are required for assembly of
the functional secretion system [11]. EM analysis of needle complexes
with deletion of the export apparatus membrane proteins shows a
loss of density located in the inner membrane rings of the basal body
which corresponds to the socket and cup region, thought to function
respectively as an anchor for the inner rod and an entry point for
substrates [22,67] (see below), suggesting that the export apparatuscontributes to its formation [11]. Recent in situ cryo-electron tomogra-
phy studies of the T3SS injectisome reveal the organization of some ex-
port apparatus features (for instance the ATPase oligomer and export
gate)which are absent in puriﬁed needle complexes [68,69].While little
is known about the structure of themembrane components SpaP, SpaQ,
and SpaR, the cytoplasmic domains of SpaS and InvA (andhomologs), as
well as the ATPase have been structurally characterized.
4.1.1. The autoprotease
SpaS, sometimes referred to as amolecular switch for its potential role
in controlling the chronology and speciﬁcity of substrate secretion, has an
N-terminal trans-membranedomain connected by awell-conservedﬂex-
ible linker to a globular C-terminal cytoplasmic autoprotease domain. The
autoprotease has a conserved NPTH sequencemotif and self-cleavage oc-
curs between the asparagine andproline residues via an intein-likemech-
anism involving asparagine cyclization [70,71]. The two subdomains
produced by self-cleavage tightly associate and structures of SpaS [70]
(Salmonella), EscU [70] (EPEC), Spa40 [72] (Shigella), YscU [73,74]
(Yersinia), and FlhB [75] (ﬂagellar homolog) have been solved. The con-
served fold consists of a central β-sheet and four α-helices, with the
cleavage motif situated on a short surface-exposed loop. Self-cleavage
alters the electrostatic surface of the auto-protease, which may function
biologically as a switch mechanism, changing from export of “early sub-
strates” (needle and rod) to “late substrates” (needle tip and translocon)
as non-cleaving mutants have defective secretion proﬁles of late sub-
strates and effectors [70,76,77]. Non-cleavingmutants also have aberrant
localization of chaperone/effector complexes at the inner membrane,
suggesting that cleavage may support targeted and speciﬁc docking of
these complexes to the export apparatus [77]. Interestingly, a non-
cleaving YscUmutant secreted tip proteinwhen the N-terminal secretion
signal of an effectorwas grafted onto the tip protein, also indicating a role
in recognition of effectors [76]. Additionally, in EPEC the autoprotease do-
main directly interacts with the inner rod [78], and associates with the
“ruler” protein [25], although the signiﬁcance of these interactions and
how they contribute to substrate switching and assembly is not under-
stood. Unlike the export ring pore (see below), the autoprotease has
only been observed as a monomer, although it is possible that multiple
copies are present in the assembled export apparatus.
4.1.2. The export gate
The export apparatus component InvA (MxiA in Shigella, YscV
inYersinia) oligomerizes [12,79] to form a cytoplasmic export ring pore.
Structures of InvA cytoplasmic domain [80,81] (as well as the ﬂagellar
homolog FhlA) [82–84] captured amonomeric formof the protein; how-
ever, the cytoplasmic domain of MxiA crystallized in a closed, planar
nonameric ringwith an external diameter of 110–170 Å, a pore diameter
of ~50 Å and a depth of ~55 Å (Fig. 1D) [79]. The monomer is composed
of four conserved subdomains, the ﬁrst of which is structurally similar to
the E subunit from the peripheral stalk of the archael A0A1 ATP synthase
[79–81]. The nonameric ring in the crystal structure is formed by interac-
tions between subdomains 1 and 3, with subdomain two situated at the
external edge of the ring, a conformation supported as biologically rele-
vant for secretion bymutational analysis of key interacting residues [79].
Electron cryo-tomography of ﬂagella with a deletion of FlhA showed a
loss of density in the toroidal region situated between the inner mem-
brane rings of the base and the cytoplasmic ATPase, consistent with the
size of the nonameric MxiA ring [79]. This data suggests a model in
which T3SS substrates are unwound from their cognate chaperone at
the site of the ATPase (see below) and funneled into the export ring
pore, which facilitates passage of the substrate to the mouth of the nee-
dle complex channel, a step that may be energetically enabled by proton
motive force [79]. The role of the remaining membrane components of
the export apparatus remains unknown and future structural work is re-
quired to construct a comprehensivemodel of how the export apparatus
functions to deliver and regulate passage of substrates to the needle
complex.
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The T3SS has a dedicated ATPase that is structurally similar to the
β-catalytic subunit of the F1 ATPase. The structure of the T3SS ATPase
in EPEC, EscN [85] has been solved, as well as the ﬂagellar homolog
FliI [86]. The ATPase has three domains: an N-terminal domain thought
to facilitate oligomerization into a homohexamer [87,88], a central
ATPase domain that binds ATP via a conserved Rossmann fold, and
a C-terminal domain, which is the proposed binding site of the
chaperone/effector complex [39,85]. The in silicomodel of the ATPase
hexamer, based on interactions between the α- and β-subunits of the
heterohexameric F1-ATPase, suggests a circular complex with an outer
diameter of 105 Å, and an inner pore diameter ranging from 30 to
50 Å, as well as 6 ATP binding sites located at the consecutive dimer in-
terface of adjacentmonomers [85]. The structure of the ﬂagellar ATPase
accessory protein, FlgJ, (as well as a Chlamydia trachomatis T3SS homo-
log CT670 [89]) was also solved and shown to be structurally similar to
the F1F0-ATPase central stalk γ subunit; it is proposed these proteins
facilitate hexamerization of the ATPase by binding in a 1:6 ratio, likely
orientating the ATPase such that the C-terminal domain faces themem-
brane and export gate [90]. Thus far, little is known about how the
ATPase coordinates with the so-named “sorting platform” [91], a com-
plex localized to the cytoplasm and proposed to include SpaO, OrgB
(homologous to the peripheral stalk protein of F-ATPase) and other ex-
port apparatus components (SpaP, SpaQ, SpaR, and SpaS) to transport
substrates in a regulated, hierarchical fashion.
4.2. The basal body
The portion of the needle complex embedded in the bacterial inner
and outer membranes is called the basal body; remarkably, despite
the 3.5 MDa size of the needle complex, the basal body is composed of
three proteins (InvG, PrgH, and PrgK in Salmonella) that are ~60 kDa
or smaller [8]. The needle complex has been studied by cryo-EM
(Salmonella) [67,92] and negative stain EM (Shigella) [93], revealing a
common overall architecture consisting of a series of stacked rings
with a wide base and neck-like region. Recently, in situ cryo-electron
tomography was used to study Shigella, Salmonella and Yersinia
injectisomes, the latter of which has never been puriﬁed [68,69]. The
recent EMmapof the Salmonella needle complexwith improved resolu-
tion [67], alongwith new crystal structures of the periplasmic and cyto-
plasmic domains of PrgH, and the periplasmic domain of InvG in
conjunction with customized Rosetta modeling algorithms [94] have
led to the most rigorous model to date of the possible oligomerization
interfaces within the major ring components of the T3SS basal body
(Fig. 1C).
4.2.1. The inner membrane rings
The inner membrane portion of the basal body consists of two
stacked rings, inner membrane ring 1 (IR1), located in the periplasm
and inner membrane ring 2 (IR2) located in the cytoplasm. The IM
ring is composed of oligomers of PrgK and PrgH [17]. Nano-gold labeling
and EM show that the C-terminal region of PrgH localizes to the peri-
plasmic region, where it forms a 24-mer ring, which encompasses a
smaller diameter 24-mer ring of the N-terminal domain of PrgK
[17,67]. PrgK is predicted to be anchored to the inner membrane by its
lipidated N-terminus [10], with the N-terminal domain positioned in
the periplasm, followed by a transmembrane helix and small cytoplas-
mic domain. Crystallization of the N-terminal domain of the EPEC
PrgK homolog EscJ produced a superhelical organization in the crystal
lattice, with 24 subunits in a complete turn of the helix [95]. Flattening
of the helix produced a ring structure composed of 24 subunits of EscJ
with a diameter of 180 Å, similar to the diameter observed in EM
maps of Salmonella IR rings [95]. PrgH contains a single transmembrane
helix, which divides the protein into a cytoplasmic N-terminal domain
and a periplasmic C-terminal domain [17]. The structures of the peri-
plasmic [94,96] and cytoplasmic [94] domains of PrgHhave been solved.The PrgH periplasmic domain contains two ring buildingmotifs (a con-
served fold consisting of two α-helices folded against a β-sheet) [96],
whereas the cytoplasmic domain contains a fork head associated
(FHA) domain, as observed in structures of homologs in Shigella
[97,98], Yersinia [99,100] and Chlamydia (PDB ID: 3GQS).While FHA do-
mains commonly bind phosphorylated threonines, the FHA residues
that bind phosphothreonines are poorly conserved among T3SS homo-
logs [94]. However, deletion of the FHA domain in Salmonella leads to
the formation of needle-less basal body, suggesting a role in T3SS as-
sembly. A deﬁnitive biological role for this domain has not been eluci-
dated, although modeling predicts it faces the cytosol, rendering it
available to mediate protein–protein interactions [94].
4.2.2. The outer membrane ring
The outer membrane ring (OM ring) and neck region of the basal
body is composed of InvG [17], a protein belonging to the secretin fam-
ily. Secretins typically oligomerize in outer-membrane embedded com-
plexes of 12–15 subunits, and are also core components of the T2SS and
Type IV pili System [101]. Assembly and oligomerization of InvG in the
outer membrane requires the assistance of a small lipoprotein, a pilotin
called InvH [14,15]. The structures of the Shigella and Pseudomonas
pilotinsMxiM [102] and ExsB [103] show little structural homology. Al-
though both contain anti-parallelβ-sheets,MxiM contains an additional
α-helix that interrupts the β-barrel like structure. MxiM is proposed to
function by ﬁrst binding its own N-terminal lipid, which is then
displaced by interactionwith the C-terminal domain of Shigella secretin
MxiD, freeing the lipid moiety for recognition by the Lol sorting path-
way and insertion into the outer membrane [102,104]. Atomic resolu-
tion data was previously only available for the periplasmic domain of
the EPEC secretin EscC [96], but a crystal structure of the homologous
domain of Salmonella InvG [94] is now available for modeling into the
Salmonella T3SS EM map. Recent cryo-EM of InvG suggests the OM
ring is composed of 15 subunits [67],which, although initially unexpect-
ed and still amatter under investigation in Salmonella and other species,
was recently supported as the most favorable oligomeric assembly of
the periplasmic domain of InvG modeled into the high resolution EM
map by Rosetta [94]. Indeed, cryo-EM analysis of the Yersinia secretin
YscC revealed that is composed of 12 subunits [105]. Both EscC and
InvG secretins contain a conserved “ring building motif” consisting
of two α-helices folded against a β-sheet, which is found at the InvG
oligomer interface, supported by mutational analysis [94], suggesting
that the fold may serve as an oligomerization scaffold [96]. The
N-terminal periplasmic domain of InvG extends into the periplasm
and contacts the C-terminal domain of PrgH, as shown by crosslinking
of the needle complex and mass-spectrometry analysis [17,106]. Addi-
tionally, recentmodeling suggests an electronegative face on the surface
of the InvG ring opposite a complementary electropositive face of the
PrgH ring may aid in ring assembly [94]. The overall assembly of the
basal body has 3-fold symmetry, with 5 subunits of InvG corresponding
to 8 subunits of IR-1 [67]. The recent EM structure of the basal body sug-
gested that the interior cup (at the cytosolic side) and socket like struc-
tures are composed of apparently individual subunits, with the socket
connecting directly to the inner rod [67]. Little is known about the pro-
tein composition and role of these observed features, but one hypothe-
sis is that the socket serves as an anchor for the inner rod, and the cup
region as an entry point for substrates. After contact with the host cell,
a signal transmitted through the needle and inner rod may trigger a
conformational change in the cup region, allowing for subsequent ex-
port of substrate [67,92].
4.3. The inner rod
The inner rod of the T3SS is located within the base of the needle
complex [92] and is proposed to form a channel through theperiplasmic
spanning region of the needle complex, physically anchoring the needle
to the base of the secretion system [22]. Based on predicted coiled-coil
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to be paralogous to the extracellular needle subunit [34] and like the
needle, believed to be capable of self-polymerization [78]. However, be-
cause the inner rod is localized within the concentric rings of the basal
body, it likely requires such an environment to fold into its functional
form, presumably hindering structural studies on the intact rod in its
isolated form.
Indeed, analysis of recombinant, puriﬁed Salmonella inner rod sub-
unit, PrgJ, and Shigella inner rod subunit, MxiI, by NMR spectroscopy
and circular dichroism revealed that the inner rod behaves as a mono-
mer, lacks tertiary structure, and is mostly unfolded, save for a short
C-terminal α-helical region (residues 65–82 in PrgJ) [107], indicating
that additional scaffolding components may be required for folding
and polymerization.
Multiple binding partners within the T3SS have been implicated for
the inner rod during assembly. The inner rod from E. coli, EscI, has been
shown to interact with the cytoplasmic domain of the autoprotease
(EscU) [78,108], with a specialized T3SS associated lytic transglycosylase
(EtgA) [108] proposed to selectively clear peptidoglycan to facilitate T3SS
assembly, and the secretin component of the basal body [78]. Additional-
ly, it has been shown to bind the gatekeeper protein (InvE/MxiC/YopN)
in Salmonella, Shigella and Yersinia (see above) [31]. Recognition of the
inner rod by the autoprotease may play a role in switching from “early”
to “late” substrates during assembly [78]. Interaction with the lytic
transglycosylase (IagB in Salmonella, IpgF in Shigella) is proposed to local-
ly clear peptidoglycan for efﬁcient assembly of the T3SS [109–111] and
contributes to virulence of Citrobacter in mice [112].
4.4. The needle
A ﬁlament termed “the needle” forms an ~50 nm long channel with
an 8 nm outer diameter and 2 nm inner diameter that extends from
basal body to the host cell, and functions as a conduit for effectors
proteins. The needle is a polymeric assembly of more than 120 copies
of a small molecular weight protomer called MxiH in Shigella [9] and
PrgI in Salmonella [113,114]. Puriﬁed needle protomer can polymerize
spontaneously to form long ﬁlaments of varying lengths, rendering
atomic resolutionmodels of the individual protomer inherently difﬁcult
to attain. Fortuitously, deletion of the last ﬁve amino acids of the
protomer prevents polymerization, and a crystal structure ofmonomer-
ic MxiHΔC5 [115] and NMR structures of monomeric BsaLΔC5 [116]
(Burkholderia) and PrgIΔC5 [117] were obtained. Structures of PscF
(Pseudomonas) [63] and YscF [64] (Yersinia) were also obtained in com-
plex with their respective heterodimeric chaperones (see Class III chap-
erones section). MxiH, BsaL and PrgI consist of N-terminalα-helix (α1)
and a C-terminal α-helix (α2), connected by conserved central region
with a PxxP sequence motif (x = S, D or N). The ﬁrst 3, 8, and 19
N-terminal residues of PrgI, BsaL andMxiH, respectively, are disordered
and have less sequence conservation than the central region and
C-terminal helix [115–117].While truncation of the ﬁve C-terminal res-
idues of the needle protomer allowed elucidation of the monomeric
structures, these mutants are non-functional, and thus further probing
of the protein–protein interactions that permit needle polymerization
requiresmodels of the full-lengthmonomer, aswell as the intact needle
ﬁlament. A systematic mutagenesis study identiﬁed a soluble full-
length PrgI and MxiH double valine to alanine mutant (V65A V67A in
PrgI), referred to as PrgI⁎ and MxiH⁎ [118]. NMR and x-ray structures
of PrgI⁎ show that the last ﬁve residues extend the C-terminal α2
helix [118]. PrgI⁎ spontaneously polymerizes in vitro and Fourier-
transform infrared spectra and Magic-angle Spinning solid-state NMR
spectroscopy identiﬁed a helical to beta-sheet conformational change
in the C-terminal region of PrgI⁎ upon conversion from monomer to
polymer, suggesting that protomer refolding is required for assembly
of the needle [118].
A hybrid approach using x-ray ﬁber diffraction, electron microscopy
and docking of protomer structures to EMmapswas used to address thequestion of how the needle protomer assembles to form a ﬁlament, and
to characterize the helical architecture and dimensions of the ﬁlament.
The ﬁrst model of the Shigella needle was solved to ~16 Å resolution
and had 5.6 subunits/turn and a 24 Å helical pitch [119]. Docking of
the MxiH crystal structure into the EM map leads to the ﬁrst proposed
model, in whichMxiHwas oriented such that the head group, or central
region, decorated the surface of the needle, the N-terminal helix lined
the central channel, and the C-terminal helix formed the outer shell of
the needle [115]. A higher resolution cryo-EM structure solved to 7.7
Å allowed visualization of alpha and beta features of the Shigella needle
[120]. Docking of MxiH into the EM map resulted in a model with the
C-terminal region of MxiH exposed on the needle surface, and the
N-terminal helix lining the needle channel. β-hairpin structure identi-
ﬁed on the needle surface (contributed to residues 51–64 of MxiH)
appeared to interact with the head group of the subunit below in the
11-start helix [120]. Electron microscopy was also used to generate an
~18 Å model of the Salmonella typhimurium needle with an average
symmetry of 6.3 subunits per turn and a 26 Å helical pitch [121]. The
central region of the PrgI monomer was modeled into the density of
the needle map, but the resolution of the ﬁlament structure and the
structural plasticity of PrgI prevented modeling of the remainder of
the monomer.
While the models described above have provided a wealth of infor-
mation about the needle, they are limited by resolution, as inter- and
intra-subunit contacts cannot be discerned at low or medium resolu-
tion. A recent study combined solid-state NMR (ssNMR), electron
microscopy and Rosetta modeling to deliver the ﬁrst atomic model of
the Salmonella typhimurium needle (Fig. 1B) [122]. Previous EMmodels
were calculated from needles sheared from isolated basal body com-
plexes, whereas this study used recombinantly produced needles ob-
tained by in vitro polymerization. The resulting model had an 11-start
helical conﬁguration, with ~5.7 subunits per turn and an axial rise of
24 Å.Within the context of the needle ﬁlament, the secondary structure
of PrgI, as determined by conformation-dependent chemical shifts,
consists of an extended N-terminal domain, an α-helix, loop, and
C-terminal α-helix. ssNMR spectra of [1-13C] glucose labeled, [2-13C]
glucose labeled, and mixed [1/2-13C] glucose labeled needle prepara-
tions were compared to determine restraints for inter-subunit interac-
tions and intra-subunit interactions [122]. Intra-subunit contacts form
between the two α-helices, positioning the helices in a hair-pin struc-
ture. The lateral interface between subunits forms between α1–α1
andα2–α2 packing of adjacent (i ± 5, i ± 6) subunits, and the axial in-
terface includes contacts between the extended N-terminal domain and
the central loop region of the i ± 11 subunit above/below it. Rosetta
modeling was used in combination with the ssNMR distance restraints
and scanning transmission electron microscopy (STEM) data [121] to
obtain an atomic resolution model of the needle. The N-terminal region
of PrgI faces the outer surface of the needle, and the C-terminal helix,
which has higher sequence conservation between species, lines the cen-
tral channel of the needle, a topology supported by immuno-gold label-
ing studies. Recently, ssNMR analysis of the Shigella needle found that
MxiH had a similar secondary structure to PrgI in the polymerized nee-
dle, and a Rosetta homology model of MxiH generated using PrgI as
template correlated well with the cutting-edge 7.7 Å Shigella EM
map [120] and the ssNMR chemical shift data. Like the Salmonella nee-
dle model, the N-terminal region of MxiH is surface exposed, and the
C-terminal region lines the lumen of the needle, suggesting a conserved
architecture.
4.5. The tip complex
The distal end of the needle culminates in a specialized tip
complex, which plays a role in sensing contact with the host cell
[123–125], regulates secretion of effector proteins [123,125–127], and
facilitates insertion of the translocon into the host cell membrane
[123,124,126,128–131] (for a comprehensive review of the tip complex
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species and can be grouped accordingly: the Inv-Mxi-Spa family (IpaD
in Shigella, SipD in Salmonella, and BipD in Burkholderia), the Ysc family
(PcrV in Pseudomonas, LcrV in Yersinia) and Esc family (EspA in EPEC,
Bsp22 in Bordetella). The tip proteins of the Inv-Mxi-Spa family and
the Ysc family have a similar overall fold, although differ in that tip pro-
teins from the latter family have a speciﬁc chaperone and tip proteins
from the former family have a self-chaperoning domain (see below).
Tip proteins from the Esc family have little structural similarity to
other tip proteins, albeit the presence of a coiled-coil [66], and extend
from the distal end of the needle, polymerizing into ﬁlamentous assem-
blies [133–137] which likely serve species-speciﬁc functions during
pathogenesis. The focus of this section will be limited to the Mxi-Inv-
Spa family of tip proteins; for more information on the Ysc family,
refer to structural studies of LcrV [138–141] and an in-depth review of
PcrV [132].
Structural characterization of SipD [142,143], IpaD [144,145], and
BipD [144,146,147] indicate a conserved fold, consisting of three
domains with an overall dumbbell type appearance: an N-terminal
α-helical hairpin packs against a central long coiled-coil domain, with
a mixed α/β domain, located at the end of the central coiled-coil, lying
opposite the N-terminal domain. The N-terminal α-helical hairpin is
proposed to act as a self-chaperoning domain, as its fold is similar to
that of the needle subunit, and it may mimic interactions with the
needle [144], preventing premature oligomerization of the tip protein
in the bacterial cytoplasm [148]. The interface formed between the
needle and tip has been probed in Shigella [149] as well as Salmonella
[143,150]. In Shigella, an interaction occurs between the PSNP motif of
MxiH and IpaD. This interaction is not possible without a reorganization
of the proposed self-chaperoning domain of IpaD. A crystal structure
of a PrgI-SipD fusion in combination with mutational analysis convinc-
ingly demonstrates that the self-chaperoning region of SipDmust be de-
leted (in vitro) for interaction with PrgI to occur and that PrgI interacts
with the concave face of the central coiled-coil with residues that
make contacts with a helix of the N-terminal domain in the full-length
PrgI structure [143]. This interaction face is consistent with NMR
paramagnetic relaxation enhancement studies between PrgI and SipD
[150]. A model of the pentameric [151] Salmonella SipD tip complex
atop the Shigella needle modeled by cryo-EM [115] with the concave
face of the SipD central coiled coil assembling around the outer surface
of the needle suggests an open conformation, with the inner channel of
the needle accessible and SipD forming an outer diameter of 140 Å
[143]; however, SipD/PrgI interaction has not yet been reworked
in the context of the recent Salmonella ssNMR needle model [152].
High resolution structural studies of the tip complex in the context of
the polymerized needle will be required to determine how the self-
chaperoning domain refolds to allow tip assembly, and how the tip
complex regulates secretion of effector proteins and insertion of the
translocon into the host cell membrane.
Bile salts are present at high concentrations in the host duodenum,
and interact with the tip proteins of infecting Shigella and Salmonella;
however, binding of bile salts to tip protein have apparently contrary
effects on the invasiveness of Shigella and Salmonella. Interaction of
IpaD with bile salts activates IpaD and stimulates recruitment of
the translocon component IpaB [131,153], whereas bile salts repress
invasiveness of Salmonella [154]. The bile salt deoxycholate interacts
with IpaDα3 andα7 of the central coiled-coil, and induces a conforma-
tional change upon binding [145,155]. Three reports demonstrate
binding of SipD to bile salts deoxycholate, taurodeoxycholate and
chenodeoxycholate, although they describe different positions of the
bile salt binding cleft [142,143,156].
4.6. The translocon
Upon contact with the host cell, the translocon components of
the T3SS are secreted and form a pore in the host cell membrane[157–159], a step that is required for delivery of effector proteins to
the host cell cytoplasm. The translocon is assembled from three compo-
nents: a hydrophilic translocator (or tip complex; see above), a major
hydrophobic translocator and a minor hydrophobic translocator. The
so-termed major hydrophobic translocator contains two predicted
transmembrane regions, while the minor translocator contains one
membrane-associated region. In Salmonella the translocon forms a
pore with an inner diameter of approximately 3.5 nm [160]. Atomic
forcemicroscopy of the EPEC translocon suggests a complex of 6–8 sub-
units with an outer diameter of 55–65 nm and a height of 15–20 nm
protruding above the membrane plane [161].
The hydrophobic components of the translocon have been recalci-
trant to structural studies, perhaps owing to the transmembrane
regions as well as the myriad of conformations and interactions they
must likely form, for example: complex formation with cytoplasmic
chaperone, export in a presumably partially unfolded state through
the needle, subsequent interaction with needle tip and/or translocon
partners, oligomerization to form a functional pore, insertion into the
host cell membrane, interaction with host lipids, and ﬁnally interaction
with host proteins within the host cytoplasm. Current structures of the
translocon proteins are restricted to peptides of the translocators in
complex with their chaperone [56,60,61], as well as a protease-
resistant N-terminal segment of themajor translocator [162]. The struc-
ture of a peptide of theN-terminal chaperonebindingdomain of Shigella
major translocator IpaB [60,61], a peptide of Pseudomonas minor
translocator PopD [56], and a peptide of Yersinia minor translocator
YopD [58] in complex with their respective chaperones IpgC, PcrH,
and SycDwere solved by x-ray crystallography. Interestingly, the chap-
erone appears to bind both the major and minor translocator in the
same cleft. Despite low sequence identity (21%) the N-terminal regions
of IpaB and Salmonella SipB were found to both form a well conserved
extended coiled-coil consisting of 3 anti-parallel helices [162]. Since
the needle, tip and translocon all possess a coiled-coil motif, it appears
this is an important structural motif in the assembly of the functional
secretion system.
High resolution EMdata and/or atomic level structural data will pro-
vide insight into how the pore regulates passage of effectors into the
host cell, and help validate or disprove proposed models of assembly
such as the “three-tiered ring model” [163] in which each hydrophobic
component forms a homo-oligomer,with themajor component embed-
ded in the membrane and the minor component associated with the
membrane and in contact with the tip complex, or another alternate as-
sembly model in which the hydrophobic components form a hetero-
oligomer that then associates with the tip complex [163].
5. Transport of effectors through the T3SS
Since the diameter of the T3SS needle ﬁlament (~20 Å) cannot ac-
commodate passage of folded effector proteins, it has long been pre-
sumed that after release of the chaperone at the site of the export
apparatus, effectors are fed through the secretion system needle in an
unfolded form. Recently, this concept was elegantly illustrated by
cryo-EM and single particle analysis of “substrate-trapped” Salmonella
injectisomes [164], as well as biochemical and functional analysis of
Shigella substrate-trapped injectisomes [165]. The substrate, Salmonella
effector protein SptP, or Shigella IpaB was effectively trapped during
secretion through the injectisome by fusion of a stable protein to its
C-terminus, which cannot be unfolded by the T3SS apparatus, thus
preventing efﬁcacious secretion and subsequently blocking the secre-
tion channel. Negative stained EM analysis of substrate-trapped
injectisomes showed a bulbous protrusion at the distal needle tip, indi-
cating that effector refolding occurs spontaneously after secretion; addi-
tionally, immunogold labeling localized the C-terminal fusion to the
base of the basal body, demarcating the substrate entry point. Difference
maps between the wild type needle complex and substrate-trapped
needle complex show additional density along the length of the inner
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pectedly reveal a change in density along the circumference of the
basal body IR-1 [164]. To summarize, the unfolded substrate enters
the secretion channel in a polarized fashion, leading with the N-
terminus, and travels the length of the needle (800 Å); upon exiting
the needle channel, the substrate appears to spontaneously refold.
Due to the resemblance of the T3SS to a syringe, it has been intuitively
thought that delivery of effectors to the host cell occurs via a one-
step “microinjection” mechanism, by which the effector travels
through the injectisome, bypassing the bacterial and host membranes,
to reach the host cytoplasm. However, recent work has led to the pro-
posal of an alternate two-step method, in which T3SS effectors and
translocators are secreted prior to host cell contact and localize to the
bacterial surface; after contact with the host cell, the hydrophobic
translocators are proposed to insert into the host cell membrane and fa-
cilitate entry of effectors, much like binary AB toxin delivery [166,167].
Further work is required to deﬁnitively show whether the host mem-
brane embedded translocon forms a continuous channel with the tip
and needle ﬁlament, and/or functions independently as a pore to
allow transport of effectors localized at the bacterial surface.6. Structural overview of Salmonella effectors
The overall structure of the T3SS apparatus is remarkably well con-
served between species; however, the number and activities of T3SS ef-
fector proteins that are passaged through the system vary extensively
between species, as each species possesses a uniquely adapted set of
effectors that promote survival and replication of the bacteria within
the host. Nonetheless, there are some common themes that are general-
ly conserved amongst effectors from all species such as modularity,
functional mimicry, and spatial and temporal regulation of effector ac-
tivity [168]. Effector proteins provide a sophisticated mechanism for
tampering with the host cell physiology to promote survival of the
bacteria— unlike bacterial toxins, many effector-mediatedmodiﬁcations
of host proteins are reversible; in fact, the activities of some effectors are
antagonistic, which allows the bacteria ﬁne-tuned control over host pro-
cesses. In this section we will conduct a brief survey of Salmonella effec-
tors that have been structurally characterized (see Table 4 and Fig. 2).
Excellent recent reviews provide a more extensive survey of T3SS effec-
tor proteins [168–170].Table 4
Structures of Salmonella effectors.
T3SS
secretion
Effector Activity Host interacting partner
SPI-1 SipA Actin bundling F-actin
SopA HECT3 Ubiquitin ligase Ubiquitin conjugating en
UbcH7
SopB (N) GDI, (C) Phosphoinositide phospha-
tase
Cdc42
SopE GEF Cdc42, Rac1, Rab5
SopE2 GEF Cdc42, Rac1
SptP (N)GAP, (C) Tyrosine phosphatase Cdc42, Rac1
PipB2 Kinesin light chain
SPI-2 SifA (N) SKIP interacting (C)GEF RhoA, SifA kinesin intera
SseI (C) Cysteine protease TRIP6, IQGAP1
SspH2 E3 ligase PKN1
SpvB ADP-ribosyltransferase actin
SpvC Phosphothreonine Lyase Dual-phosphorylated M
Highest activity for phos
Abbreviations: (N), N-terminal domain; (C), C-terminal domain.6.1. Modulation of RhoGTPases
Rho GTPase signaling is commonly targeted by bacterial effectors,
perhaps due to their central role in regulation of host actin and cytoskel-
eton dynamics, as well as numerous signal transduction pathways. Rho
GTPases act asmolecular switches, alternating between an inactive GDP
bound state and an active GTP bound state. In the active state GTP
bound state, Rho GTPases Cdc42, Rho, and Rac interact with more
than 30 potential eukaryotic effector proteins, such as kinases, conse-
quently activating down-stream signaling pathways [171]. RhoGTPases
have a conserved small globular α/β fold with two ﬂexible switch
regions (switch I and switch II) and a conserved P-loop (phosphate
binding loop) which coordinate the nucleotide and an Mg2+ ion, and
undergo a conformational change after hydrolysis of GTP to GDP
[172]. Hydrolysis of GTP is intrinsically slow, and activity of the Rho
GTPase is regulated by guanine–nucleotide exchange factors (GEFs),
GTP activating proteins (GAPs) and guanine nucleotide dissociation in-
hibitors (GDIs) [173]. Salmonella effectors SopE and SopE2 are bacterial
GEFs that catalyze Cdc42 and Rac1 exchange of GDP for GTP [174–176],
a function that could not be extrapolated from sequence analysis as the
bacterial GEFs show no sequence or structural homology to eukaryotic
GEFs [177,178]. Indeed, SopE has a V-shaped fold composed of two
3-helix bundles and a catalytic GAGA motif connecting the two sides
of the ‘V’. In the co-crystal structural, SopE contacts switches I and II of
Cdc42, mimicking interactions of eukaryotic GEFs with key Cdc42
residues, to disrupt binding of the nucleotide and facilitate its dissocia-
tion [177]. SifA, a SPI-2 secreted Salmonella effector may contact
Rho-GDP through a C-terminal domain which has similar fold to SopE
[179,180]; however, it belongs to the WxxxE family of bacterial effec-
tors, named for the conserved Trp and Glu residues in the catalytic
site, and GEF activity has not yet been demonstrated [181]. The
N-terminal GAP domain of Salmonella effector SptP forms a four-helix
bundle that inserts between switches I and II of the GTPase and contacts
the β-phosphate of GTPwith a catalytic arginine residue [182], mimick-
ing the interactionmade between eukaryotic GAPs and Cdc42, despite a
lack of sequence and structure conservation. The N-terminal domain of
Salmonella effector SopB has GDI-like activity towards Cdc42, and con-
tacts switches I and II of the GTPase via a helical bundle and mimics in-
teractions of eukaryotic GDIs to prevent dissociation of GDP nucleotide
[183]. The structures of Salmonella GTPase binding domains reveal that
they contain a mostly helical fold and share little structural homologyStructure PDB
(N)SipA/InvB 2FM8 [45]
(N)SipA 2FM9 [45]
(C)SipA 1Q5Z [199]
zymes (E2) UbcH5a, UbcH5c, SopA/E2 UbcH7 3SY2 [192]
SopA 2QZA, 2QYU
[191]
SopB/Cdc42 4DID [183]
SopE/Cdc42 1GZS [177]
SopE2 1R9K [178]
(N)SptP/SicP 1JYO [42]
SptP/Rac1 1G4U [182]
SptP 1G4W [182]
PipB2 N-term 2LEZ
cting protein (SKIP) SifA/SKIP 3HW2 [180]
SifA/SKIP 3CXB [179]
SseI 4G29 [196]
SspH2 3G06 [193]
SpvB 2GWK [202]
APKs
pho-p38
SpvC 2Q8Y [195]
SpvC + phosphothreonine
peptide
2Z8P [194]
Fig. 2. Overview of structurally characterized Salmonella effectors and their role in host cell pathways. Left panel, Salmonella SPI-1 effectors are shown in blue font and SPI-2 effectors are
shown in green font. After entry into the host cell, Salmonella survives and replicates within the Salmonella containing vacuole. SPI-1 and SPI-2 effectors target many host pathways; here
we highlight structurally characterized effectors that target RhoGTPase signaling, the ubiquitin pathway, cytoskeleton components, and also effectors that covalentlymodify host proteins.
A) effectors SopE (green), SopB (orange), and SptP (red) interact with switch regions (shown in cyan) of Cdc42 and/or Rac1 (blue). B) Hect-type E3 ligase SopA (purple) in complexwith
host E2 ubiquitin conjugating enzyme UbcH7 (gray) and NEL E3 ligase SspH2 (yellow). C, SifA (red) in complex with kinesin binding protein SKIP (gray), ADP Ribosyltransferase SpvB
(purple) and actin binding SipA (blue) all interact with and/or modify host cytoskeleton proteins. D) Many effectors covalently modify their host targets, such as phosphothreonine
lyase SpvC (yellow), cysteine protease SseI (green) and the C-terminal tyrosine phosphatase domain of SptP (red). PDB codes of Salmonella effector structures used for thisﬁgure are listed
in panels A–D.
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set of GTPase regulators to ﬁnely tune host GTPase activity during
infection.
6.2. Targeting the host ubiquitin pathway
The host ubiquitin pathway plays a pivotal role in numerous host
processes such as protein degradation, DNA repair, cell cycle control,
and protein trafﬁcking (see reviews [184–186]), and bacterial effectors
have evolved to commandeer various aspects of the ubiquitin pathway
[187]. Three enzymes facilitate the covalent attachment of ubiquitin to
speciﬁc lysine residues of a target protein either as a mono-ubiquitin
or poly-ubiquitin chain: 1) Ubiquitin activating enzyme E1 recruits
and binds ubiquitin via a covalent thioester bond, 2) ubiquitin conjugat-
ing enzyme E2 transfers ubiquitin from E1 and 3) ubiquitin ligase E3
interacts with E2 and transfers ubiquitin to the lysine of the target sub-
strate [188]. Structurally characterized Salmonella effectors SopA and
SspH2 are both ubiquitin E3 ligases, although SopA belongs to the
HECT-type E3 ligase family [189] and SspH2 belongs to the NEL (Novel
E3 Ligase) family [190]. SopA has little sequence conservation with
eukaryotic HECT E3 ligases, except for a conserved motif in the active
site, but is structurally similar in that it contains an L-shaped bilobal
architecture with an N-lobe that binds E2 and a catalytic C-lobe with aconserved cysteine that can form a thioester bond with ubiquitin
[191,192]. A co-crystal structure of SopA in complex with host E2
UbcH7demonstrates that SopAbinds the same face of UbcH7 as eukary-
otic E3 ligases and comparison of the structure to that of an EHEC homo-
log NleL in complex with UbcH7 shows the C-lobe can move 180° on a
ﬂexible hinge region, a motion that is important for ubiquitin transfer
[192]. The SspH2 structure revealed two domains: an N-terminal
leucine-rich repeat (LRR) which mediates protein–protein interactions
and an all helical C-terminal E3 ligase domain with a catalytic cysteine
[193]. The catalytic cysteine is partially buried by the LRRs, which may
represent an auto-inhibited conformation, preventing pre-mature in-
teraction with host proteins [193]. The known structures of Salmonella
E3 ligases show that markedly different structures have evolved to
transfer ubiquitin to a subset of host cell proteins, likely dictated by
their speciﬁc protein–protein interaction domains. This process appears
regulated in time as SopA is secreted by the SPI-1 T3SS and SspH2 is
secreted by SPI-2 T3SS (another Salmonella E3 ligase SspH1 is secreted
by both the SPI-1 and SPI-2 T3SSs).
6.3. Covalent modiﬁcation of host targets
Another mechanism deployed by T3SS effectors is covalent
modiﬁcation of host cell proteins. Recent structures of Salmonella
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well as the structure of the C-terminal tyrosine phosphatase domain of
SptP [182] exemplify effectors that covalently modify host target pro-
teins. SpvC irreversibly inactivates host signaling protein MAPK by
cleaving a phosphothreonine residue required for activity through a
β-elimination mechanism, resulting in cleavage of the C\O bond and
generation of a double bond product [194,195]. The N-terminus, al-
though disordered in the crystal structure, has a conserved D motif for
interaction with host MAPKs [195]. SpvC has an α/β fold and binds
the pT–x–pY peptide of MAPK through a central twisted 5-stranded
β-sheet and surface loops [194,195]. The phosphothreonine lyase activ-
ity of SpvC and related bacterial effectors represents a novelmechanism
for irreversible inactivation of MAPKs that has not yet been observed in
eukaryotic systems. A recent structure of the C-terminal domain of an-
other SPI-2 secreted effector, SseI, revealed a cysteine protease domain
with a conservedCys-His-Asp catalytic triad [196]. This domain of SseI has
sequence and structural similarity to Pastuerella multocida toxin (PMT),
which has glutamine deamidase activity towards the α-subunit of
heterotrimeric GTPases. The biological targets of SseI have yet to be iden-
tiﬁed, and catalytic activity was not observed in in vitro assays [196]. The
Salmonella SPI-1 effector SptP, has a C-terminal tyrosine phosphatase do-
main with sequence conservation (15%) to eukaryotic tyrosine phospha-
tase PTP1B. Structural analysis reveals this domain of SptP adopts the
canonical tyrosine phosphatase fold with a twisted β-strand fold at the
core, and a cluster of 4 helices at one end and 2 helices at the other
[182]. The active site contains a conserved P-loopwith a catalytic cysteine
[182]. These structures provide examples of Salmonella effectors that
select host substrates for covalent modiﬁcation to control signaling path-
ways in a reversible or irreversible manner.
6.4. Interaction with the host cytoskeleton
Multiple Salmonella effectors interact with components of the host
cytoskeleton, such as actin and microtubule binding proteins. While
some effectors alter actin dynamics by regulating activity of small
GTPases involved in signaling pathways controlling actin dynamics
(see above), others directly bind or modify actin. Crystal structures of
Salmonella SipA and SpvB are examples of two such effectors. SipA
contains a C-terminal domain that directly binds actin [197] to stabilize
F-actin, as well as promote polymerization of G-actin [198]. EM analysis
demonstrates that SipA binds actin, linking subdomain 4 of actinmono-
mer i to subdomain 1 of monomer i+ 3 of the adjacent actin ﬁlament
[198,199]. The central region of the SipA actin binding domain has a
globular fold with N-terminal and C-terminal extensions on either
side that are proposed to behave as a molecular stapler, connecting
and stabilizing actinﬁlaments [199]. SpvB, another actin-modulating ef-
fector, ADP ribosylates actin to inhibit polymerization [200,201]. Struc-
tural studies of SpvB reveal 2 nearly perpendicular β-sheets forming a
canonical ADP ribosyltransferase α/β fold and show binding of NAD in
a manner similar to other characterized members of the family [202].
SipA and SpvB exemplify the diverse, and sometimes antagonistic,
mechanisms Salmonella effectors use to modulate host proteins.
Additionally, SP1-2 effector SifA (see above), contacts SifA Kinesin
Interacting Protein (SKIP) via its N-terminal domain, an interaction
that likely serves to localize SifA to microtubules through binding of
SKIP to themotor protein kinesin [31,179,180]. Although themechanism
is not yet well understood, SifA is necessary for tubulation of the
Salmonella phagosome and a ΔsifA mutant is attenuated for virulence
in mice [203,204].
This section provides only a brief survey of Salmonella effectors that
have been structurally characterized. Elucidating the structures of these
effectors is particularly valuable in the instances for which activity can-
not be gleaned from the amino acid sequence. Structural studies of
bacterial effectors that do have sequence conservation to eukaryotic
proteins provide information not only about the bacterial effector, but
also of the class of host protein it emulates.7. Concluding remarks
Recent strides have been made in structural characterization of the
T3SS. An improved EMmap of the needle complex provides new details
of its symmetry and substructures [67]. New crystal structures of the
periplasmic domain of OM ring component InvG and the cytoplasmic
domain of IM ring component PrgH in combinationwith Rosettamodel-
ing provide the most rigorous model of oligomeric interactions in the
basal body complex [94]. Great advances have been made in determin-
ing the architecture of the Salmonella [122] and Shigella [205] needles by
a combination of ssNMR, electron microscopy and Rosetta modeling.
These studies convincingly demonstrate that the conserved residues of
the needle protomer line the channel of the needle, while the variable
N-terminal region decorates the surface of the needle. At the cytoplas-
mic side of the T3SS, a remarkable nonameric structure of the gate pro-
tein MxiA provides visualization of a major component of the export
apparatus [79]. New structures have emerged of class II translocon
chaperones [56–61], as well as class III heterodimeric needle chaper-
ones [63–65] and more than eight Salmonella virulence effectors in the
last ﬁve years [179,180,183,191–194,196].
However despite recent advances, much about the structure and as-
sembly of the T3SS is yet to be discovered. For example, little is known
at themolecular level regarding the innermembrane components of the
export apparatus, as well as the energetics behind translocation of sub-
strates through the extensive path of the secretion system needle. Less
is known about the structure of the inner rod in the periplasm of the
needle complex, and the membrane domains of the basal body compo-
nents. Paramount to our understanding of the T3SSmediated delivery of
effectors into the host cell will be structural analysis of the translocon
pore-forming complex. Collectively, a piecing together of these T3SS
molecular events using a multidisciplinary approach of biophysical,
biochemical and cellular microbiology are generating an evolving
model of this essential process to the pathogenicity of the major Gram
negative bacterial pathogens.
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